GRADE 3B FOLLICULAR LYMPHOMA

Clinical trials for GRADE 3B FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new GRADE 3B FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for GRADE 3B FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 1 Not yet finished but already full! 6 Completed 2

Experimental CAR-T therapy takes aim at tough blood cancers

Disease control Not yet recruiting

This early-stage trial will test a new immune cell therapy called CT1194D CAR-T in 20 adults with relapsed or refractory B-cell cancers (lymphoma or leukemia). The main goals are to check safety, find the right dose, and see how long the cells last in the body. Researchers will a…

Matched conditions: GRADE 3B FOLLICULAR LYMPHOMA

Phase: PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated Jun 27, 2026 07:52 UTC

GRADE 3B FOLLICULAR LYMPHOMA

Get alerted when new GRADE 3B FOLLICULAR LYMPHOMA trials appear

Experimental CAR-T therapy takes aim at tough blood cancers